Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.426,81
0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mersana Therapeutics Inc (MRSN) Mersana Therapeutics Inc (MRSN) Notizie

Mersana Therapeutics Inc

MRSN
2,04
0,06 (3,03%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202422:45EDGAR2Form SC 13D/A - General Statement of Acquisition of..
14/11/202423:45EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202417:00APSThis Particular Biotech Stock Is Soaring On Two Key..
13/11/202414:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202413:27EDGAR2Form 8-K - Current report
13/11/202413:00GLOBEMersana Therapeutics Provides Business Update and Announces..
06/11/202414:00GLOBEMersana Therapeutics to Host Third Quarter 2024 Conference..
29/10/202421:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202421:26EDGAR2Form 144 - Report of proposed sale of securities
15/10/202412:55EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/10/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:20EDGAR2Form 144 - Report of proposed sale of securities
07/10/202423:19EDGAR2Form 144 - Report of proposed sale of securities
07/10/202423:18EDGAR2Form 144 - Report of proposed sale of securities
07/10/202423:18EDGAR2Form 144 - Report of proposed sale of securities
04/10/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:06EDGAR2Form 144 - Report of proposed sale of securities
13/8/202414:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:18EDGAR2Form 8-K - Current report
13/8/202413:00GLOBEMersana Therapeutics Provides Business Update and..
06/8/202414:00GLOBEMersana Therapeutics to Host Second Quarter 2024 Conference..
12/6/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:25EDGAR2Form 8-K - Current report
22/5/202414:00GLOBEMersana Therapeutics to Present at Upcoming Investor..
17/5/202414:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
09/5/202423:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/5/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:10EDGAR2Form 8-K - Current report
09/5/202412:59GLOBEMersana Therapeutics Provides Business Update and..
03/5/202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
02/5/202414:00GLOBEMersana Therapeutics to Host First Quarter 2024 Conference..
04/4/202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
28/2/202422:08EDGAR2Form 8-K - Current report
28/2/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202414:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202414:43EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
28/2/202413:07EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEMersana Therapeutics Provides Business Update and..
27/2/202414:01GLOBEMersana Therapeutics to Present at Upcoming Investor..
21/2/202414:00GLOBEMersana Therapeutics to Host Fourth Quarter and Year End..
15/2/202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 2,00 Min: 1,9507 Max: 2,115
Chiusura: 1,98

La tua Cronologia

NASDAQ
MRSN
Mersana Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network